Can Efflux Transporters Be Modulated to Improve Therapeutic Outcomes?
Yes, modulating efflux transporter activity presents an opportunity to enhance drug efficacy and reduce toxicity. Inhibitors or inducers of efflux transporters can be co-administered with therapeutic drugs to modify their pharmacokinetic profiles. However, such strategies must be carefully balanced to avoid unwanted interactions and toxicities.
